Literature DB >> 31740520

Adult Cancer Survivors' Engagement and Interest in Patient-Centered Research.

Margaret M Lubas1, Yan Lu2, Aaron W Gehr2, Bassam Ghabach3, Bhavna Tanna3, Kalyani Narra3, Tara M Brinkman1, Rohit P Ojha4,5.   

Abstract

BACKGROUND: Limited information is available about the representativeness of survivors engaging in patient-centered research, despite the potential for threats to generalizability. We thus aimed to assess the representativeness of survivors engaged or interested in research development.
METHODS: We used data from the Health Information National Trends Survey, a nationally representative survey, to identify survivors of adult cancers. Our outcomes of interest were based on responses to questions about engagement or interest in developing patient-centered research. We estimated the ratio of relative frequencies (RRF) and corresponding 95% confidence limits (CL) of sociodemographic and survivorship characteristics between survivors engaged or interested in patient-centered research and the overall survivor population.
RESULTS: Our study population comprised 934 survivors, of whom 5% reported being engaged in patient-centered research and 26% reported an interest in participating. Relative frequencies of characteristics were discordant for engaged survivors but largely similar for interested survivors compared with all survivors. In particular, engaged survivors had a higher relative frequency of individuals ages 50 to 64 years (RRF = 1.7; 95% CL, 1.1-2.5), Hispanic (RRF = 2.9; 95% CL, 1.2-6.9), non-Hispanic Black (RRF = 2.9; 95% CL, 1.1-2.5), and unemployment (RRF = 4.7; 95% CL, 1.4-16).
CONCLUSIONS: We observed several meaningful differences in the characteristics of survivors engaged in patient-centered research compared with all survivors, which raises concerns about the generalizability of findings from such studies. IMPACT: Patient-centered research may not benefit the broader survivor community if survivors engaging in research development are not representative of all survivors. Greater attention to recruiting mechanisms is necessary to avoid creating disparities. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2019        PMID: 31740520      PMCID: PMC7007350          DOI: 10.1158/1055-9965.EPI-19-0689

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  41 in total

1.  A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).

Authors:  Sara H Javid; Joseph M Unger; Julie R Gralow; Carol M Moinpour; Antoinette J Wozniak; J Wendall Goodwin; Primo N Lara; Pamela A Williams; Laura F Hutchins; Carolyn C Gotay; Kathy S Albain
Journal:  Oncologist       Date:  2012-06-20

2.  Engaging stakeholders to improve presentation of patient-reported outcomes data in clinical practice.

Authors:  Katherine C Smith; Michael D Brundage; Elliott Tolbert; Emily A Little; Elissa T Bantug; Claire F Snyder
Journal:  Support Care Cancer       Date:  2016-05-10       Impact factor: 3.603

3.  Patient income level and cancer clinical trial participation.

Authors:  Joseph M Unger; Dawn L Hershman; Kathy S Albain; Carol M Moinpour; Judith A Petersen; Kenda Burg; John J Crowley
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

4.  Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective.

Authors:  Neeraj K Arora; Bryce B Reeve; Ron D Hays; Steven B Clauser; Ingrid Oakley-Girvan
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

5.  Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care.

Authors:  Janet S de Moor; Angela B Mariotto; Carla Parry; Catherine M Alfano; Lynne Padgett; Erin E Kent; Laura Forsythe; Steve Scoppa; Mark Hachey; Julia H Rowland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-27       Impact factor: 4.254

6.  Priorities for Patient-Centered Outcomes Research: The Views of Minority and Underserved Communities.

Authors:  Susan Dorr Goold; C Daniel Myers; Lisa Szymecko; Carla Cunningham Collins; Sal Martinez; Charo Ledón; Terrance R Campbell; Marion Danis; Stephanie Solomon Cargill; Hyungjin Myra Kim; Zachary Rowe
Journal:  Health Serv Res       Date:  2016-05-20       Impact factor: 3.402

7.  Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States.

Authors:  Shirley M Bluethmann; Angela B Mariotto; Julia H Rowland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-07       Impact factor: 4.254

8.  Managing the cancer-work interface: the effect of cancer survivorship on unemployment.

Authors:  J Kathleen Tracy; Derek Falk; Rebecca J Thompson; Lily Scheindlin; Fiyinfolu Adetunji; Jennifer E Swanberg
Journal:  Cancer Manag Res       Date:  2018-11-28       Impact factor: 3.989

9.  Exercise and nutrition for head and neck cancer patients: a patient oriented, clinic-supported randomized controlled trial.

Authors:  Lauren C Capozzi; Harold Lau; Raylene A Reimer; Margaret McNeely; Janine Giese-Davis; S Nicole Culos-Reed
Journal:  BMC Cancer       Date:  2012-10-02       Impact factor: 4.430

10.  Health Research Participation, Opportunity, and Willingness Among Minority and Rural Communities of Arkansas.

Authors:  Pearl A McElfish; Christopher R Long; James P Selig; Brett Rowland; Rachel S Purvis; Laura James; Angel Holland; Holly C Felix; Marie-Rachelle Narcisse
Journal:  Clin Transl Sci       Date:  2018-05-17       Impact factor: 4.689

View more
  2 in total

1.  From the Community to the Bench and Back Again: The Value of Patient and Community Engagement in Cancer Research.

Authors:  Amy E Leader; Andrew E Aplin
Journal:  Cancer Discov       Date:  2021-09       Impact factor: 39.397

2.  Partnering patients, caregivers, and basic scientists: an engagement model that fosters patient- and family-centered research culture.

Authors:  Dana Ketcher; Anne Bidelman; Liem Q Le; Amy K Otto; Daniel K Lester; Kim K Amtmann-Beuttner; Brian D Gonzalez; Kenneth L Wright; Susan T Vadaparampil; Maija Reblin; Eric K Lau
Journal:  Transl Res       Date:  2020-07-30       Impact factor: 7.012

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.